Overview:

The global inhalation anesthesia market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. Anesthetic inhalation is a chemical compound having anesthetic properties, which is transmitted through inhalation in the human body. This type of anesthesia can be controlled by the facemask or a vaporizer-connected tracheal tube, and another delivery device. The anesthetic agents play a key role in management of pain, respiration, blood flow, blood pressure, and heart rate during surgical procedures. Inhalational anesthesia is majorly used for general anesthetic induction and sedation purposes.

Market Dynamics:

Growing number of surgical procedures across the globe, along with growing emergence of the trauma cases worldwide are the major factors driving growth of the global inhalation anesthesia market. Additionally, increasing geriatric population, increasing cancer patient pool, rising cardiovascular, gastrointestinal, respiratory, neurological disorders among individuals are some other key factors driving growth of the target market. For instance, as per World Health Organization (WHO), around 18 Mn individuals were affected by cancer across the globe in the year 2018 and are expected to increase at a very high rate over the next decade.

In addition, increasing stress level and unhealthy diet habits among young population leading to increased growth of chronic diseases which is further expected to result in growth of the target market. Also, growing number of road accidents and rising concern level about intravenous anesthesia are among the other factor supporting growth of the target market.

Moreover, rising healthcare expenditure, increasing income level, growing healthcare access, and rising expenditure level for healthcare infrastructure development are some other factors expected to support growth of the global inhalation anesthesia market over the forecast period.

Key Trends:

Growing product launches by key players and approvals is the key trend witnessed in the global inhalation anesthesia market. For instance, in April 2020, Blue-Zone Technologies Ltd. has received approval for its DESFLURANE, USP from Health Canada to produce and launch this drug. Also, this approval is considered a first approval for a drug which needs distillation based process for production.

Regional Analysis:

For detailed understanding of market dynamics, the global inhalation anesthesia market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America is accounted for the significant revenue share in 2018, owing to early adoption of inhalation anesthesia and growing number of surgical procedures in countries in the region.

The target market in Asia Pacific region is expected to witness strong growth over the forecast period. China and India expected to hold major share in the Asia Pacific inhalation anesthesia market.

Scope of the Report:

Detailed Segmentation:

Global Inhalation Anesthesia Market, By Product Type:

• Sevoflurane
• Desflurane
• Isoflurane

Global Inhalation Anesthesia Market, By Application:

• Induction
• Maintenance

Global Inhalation Anesthesia Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Key Players Covered:

Key players operating in the global market include, Baxter International Inc., Hikma Pharmaceuticals PLC, AbbVie Inc., Fresenius SE & Co. KGaA, Jiangsu Hengrui Medicine Co., Ltd., Halocarbon Products Corporation, Piramal Enterprises Ltd., Lunan Pharmaceutical Group Co. Ltd, Novartis AG, and Eisai Co., Ltd.

Key Features of the Study:

Foresight Market Research provides detailed analysis on global market in our report- Global Inhalation Anesthesia Market by product type, application, end user, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global inhalation anesthesia market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, market expansion, and marketing tactics used overall the globe.